Business Context and Reporting Period
This Form 6-K filing by Therapix Biosciences Ltd. (referred to as "Scisparc Ltd." in the request metadata) covers the month of August 2020, with a filing date of August 3, 2020. The document serves as a notice regarding the adjournment of the Company's shareholders meeting, which was previously announced on July 31, 2020.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a procedural notice and does not contain financial statements or performance metrics.
Material Changes
There are no material financial changes reported in this document. The primary update concerns the logistical format of the shareholders meeting, which will be held remotely via Zoom videoconference on August 4, 2020, at 4:00 pm Israel Time, in compliance with Israeli Ministry of Health and safety guidelines.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary on business performance. The only risk or contingency noted relates to the requirement for shareholders to register attendance by email no later than August 4, 2020, at 12:00 pm Israel Time, including submission of identification and a Power of Attorney if using a representative.
Key Facts for Investor Verification
- The shareholders meeting is scheduled for August 4, 2020, and will be conducted entirely remotely.
- Shareholders must register attendance via email to Info@therapixbio.com by the specified deadline to participate.
- This Form 6-K is incorporated by reference into the Company's registration statements on Form F-3 and Form S-8.
- The document contains no financial data; investors should refer to Form 20-F filings for financial performance.